These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Pharmacodynamic effects of a nonpeptide antidiuretic hormone V2 antagonist in cirrhotic patients with ascites. Guyader D; Patat A; Ellis-Grosse EJ; Orczyk GP Hepatology; 2002 Nov; 36(5):1197-205. PubMed ID: 12395330 [TBL] [Abstract][Full Text] [Related]
25. [Secondary nephrogenic diabetes insipidus in the Laurence-Moon-Biedl syndrome (exploration of renal hydric homeostasis)]. Radice C; D'Amico E; Torti G Minerva Pediatr; 1971 Nov; 23(46):1968-73. PubMed ID: 5173396 [No Abstract] [Full Text] [Related]
26. Water in health and disease: new aspects of disturbances in water metabolism. Peters HP; Robben JH; Deen PM; Wetzels JF Neth J Med; 2007 Oct; 65(9):325-32. PubMed ID: 17954951 [TBL] [Abstract][Full Text] [Related]
27. [Alteration of renal function and water-salt metabolism in rats dlring development of toxic cirrhosis of the liver]. Gapon LI Patol Fiziol Eksp Ter; 1977; (3):82-4. PubMed ID: 896297 [No Abstract] [Full Text] [Related]
28. [Diabetes insipidus and osmoregulation]. Uhlich E Verh Dtsch Ges Inn Med; 1980; 86():94-9. PubMed ID: 7223046 [No Abstract] [Full Text] [Related]
29. Effects of yohimbine and prazosin on water balance in dogs with diabetes insipidus. Montastruc JL; Dang Tran L; Castillo-Ferrando JR; Morales-Olivas F; Gaillard-Plaza G; Montastruc P J Pharmacol; 1980; 11(4):441-8. PubMed ID: 7206732 [No Abstract] [Full Text] [Related]
30. Vasopressin antagonists as aquaretic agents for the treatment of hyponatremia. Palm C; Pistrosch F; Herbrig K; Gross P Am J Med; 2006 Jul; 119(7 Suppl 1):S87-92. PubMed ID: 16843091 [TBL] [Abstract][Full Text] [Related]
34. [Progress on diagnosis and therapy of water-electrolyte imbalance--water metabolism disorders]. Ishikawa S Nihon Naika Gakkai Zasshi; 1997 Oct; 86(10):1825-30. PubMed ID: 9445865 [No Abstract] [Full Text] [Related]
35. [Pathological aspects of water transport in the collecting ducts]. Bichet DG Nephrologie; 1996; 17(7):417-22. PubMed ID: 9019668 [TBL] [Abstract][Full Text] [Related]
36. [Studies on the clinical significance of the antidiuretic hormone]. Börner E Ann Univ Sarav Med; 1974; 21(1):1-53. PubMed ID: 4411001 [No Abstract] [Full Text] [Related]
37. Disorders of water metabolism. Hardy RM Vet Clin North Am Small Anim Pract; 1982 Aug; 12(3):353-73. PubMed ID: 6983760 [No Abstract] [Full Text] [Related]
38. OPC-41061, a highly potent human vasopressin V2-receptor antagonist: pharmacological profile and aquaretic effect by single and multiple oral dosing in rats. Yamamura Y; Nakamura S; Itoh S; Hirano T; Onogawa T; Yamashita T; Yamada Y; Tsujimae K; Aoyama M; Kotosai K; Ogawa H; Yamashita H; Kondo K; Tominaga M; Tsujimoto G; Mori T J Pharmacol Exp Ther; 1998 Dec; 287(3):860-7. PubMed ID: 9864265 [TBL] [Abstract][Full Text] [Related]
39. [Aquaretic drugs--a new therapeutic principle in treatment of hyponatremia?]. Hensen J; Buchfelder M; Gross P Fortschr Med; 1997 Jun; 115(17):46-50. PubMed ID: 9312543 [TBL] [Abstract][Full Text] [Related]